Lipid-Lowering Efficacy and Safety After Switching to Atazanavir-Ritonavir–Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus-Reference-Cited by-同舟云学术

Lipid-Lowering Efficacy and Safety After Switching to Atazanavir-Ritonavir–Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus

Published:2008-03 Issue:3 Volume:28 Page:323-330
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Nguyen Sean T,Eaton Susan A,Bain Amy M,Rahman Anita P,Payne Kenna D,Bedimo Roger,Herrington Jon D,Maclayton Darego O,Rodriguez-Barradas Maria C,Busti Anthony J

Publisher

Wiley

Subject

Pharmacology (medical)

Reference38 articles.

1. Didanosine-induced hypertriglyceridemia

2. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

3. Long-Term Body Composition and Metabolic Changes in Antiretroviral Naive Persons Randomized to Protease Inhibitor-, Nonnucleoside Reverse Transcriptase Inhibitor-, or Protease Inhibitor Plus Nonnucleoside Reverse Transcriptase Inhibitor-Based Strategy

4. Absence of Association Between Individual Thymidine Analogues or Nonnucleoside Analogues and Lipid Abnormalities in HIV-1–Infected Persons on Initial Therapy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV and Dyslipidemia;Contemporary Cardiology;2020-12-16

2. Diagnosis and Management of Dyslipidemia;Cardiovascular Care in Patients With HIV;2019

3. Hipercoagulabilidad con pérdida de la competencia inmunológica en paciente críticamente enfermo con síndrome de inmunodeficiencia adquirida relacionada con deficiencia de proteína C, proteína S y antitrombina III;Acta Colombiana de Cuidado Intensivo;2019-01

4. Effects of Chinese herbal medicine on hyperlipidemia and the risk of cardiovascular disease in HIV-infected patients in Taiwan;Journal of Ethnopharmacology;2018-06

5. Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort;BMC Infectious Diseases;2017-03-15